Lupin Ranks No. 1 Globally in Pharma in S&P ESG Assessment 2025
“This recognition by S&P Global places Lupin among the topmost global sustainability leaders and reinforces our long-term commitment to embedding ESG principles into our business strategy.” Ramesh Swaminathan, Executive Director, Global…
Read More...
Read More...